Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.
Agar M, Koh ES, Gibbs E, Barnes EH, Hovey E, Livingstone A, Sawkins K, Chye R, Lovell MR, Clark K, Vardy J, King M; Cooperative Trials Group for Neuro-Oncology (COGNO). Agar M, et al. Among authors: livingstone a. Support Care Cancer. 2016 Mar;24(3):1209-18. doi: 10.1007/s00520-015-2897-0. Epub 2015 Aug 21. Support Care Cancer. 2016. PMID: 26294320
Culturally and linguistically diverse patient participation in glioma research.
Lwin Z, Broom A, Cosman R, Livingstone A, Sawkins K, Good P, Kirby E, Koh ES, Hovey E; COGNO CALD working group. Lwin Z, et al. Among authors: livingstone a. Neurooncol Pract. 2014 Sep;1(3):101-105. doi: 10.1093/nop/npu009. Epub 2014 Jun 25. Neurooncol Pract. 2014. PMID: 26034622 Free PMC article.
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
Field KM, Simes J, Nowak AK, Cher L, Wheeler H, Hovey EJ, Brown CS, Barnes EH, Sawkins K, Livingstone A, Freilich R, Phal PM, Fitt G; CABARET/COGNO investigators; Rosenthal MA. Field KM, et al. Among authors: livingstone a. Neuro Oncol. 2015 Nov;17(11):1504-13. doi: 10.1093/neuonc/nov104. Epub 2015 Jun 30. Neuro Oncol. 2015. PMID: 26130744 Free PMC article. Clinical Trial.
Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.
Hovey EJ, Field KM, Rosenthal MA, Barnes EH, Cher L, Nowak AK, Wheeler H, Sawkins K, Livingstone A, Phal P, Goh C, Simes J; CABARET/COGNO investigators. Hovey EJ, et al. Among authors: livingstone a. Neurooncol Pract. 2017 Sep;4(3):171-181. doi: 10.1093/nop/npw025. Epub 2017 May 25. Neurooncol Pract. 2017. PMID: 31386014 Free PMC article.
Preferences for Immunotherapy in Melanoma: A Systematic Review.
Livingstone A, Agarwal A, Stockler MR, Menzies AM, Howard K, Morton RL. Livingstone A, et al. Ann Surg Oncol. 2020 Feb;27(2):571-584. doi: 10.1245/s10434-019-07963-y. Epub 2019 Oct 29. Ann Surg Oncol. 2020. PMID: 31664622 Review.
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D; ETOP/IFCT 4-12 STIMULI Collaborators. Peters S, et al. Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23. Ann Oncol. 2022. PMID: 34562610 Free article. Clinical Trial.
407 results